Literature DB >> 7548909

Humoral immune response in infants after BCG vaccination.

U Beyazova1, S Rota, C Cevheroğlu, T Karsligil.   

Abstract

SETTING: Child welfare division of a university-based department of pediatrics in Turkey.
OBJECTIVE: To determine specific IgM and IgG response after BCG vaccination.
DESIGN: Prospective, randomized trial.
METHODS: Serum samples of 66 infants were taken before and at 2, 4, 6 and 15 months after vaccination. 35 infants were vaccinated at the first month and 31 at the second month after delivery. An ELISA assay was performed using PPD antigen.
RESULTS: IgM antibodies increased significantly (P < 0.05) during the post-vaccination period. On the other hand IgG antibodies decreased in the second month after vaccination. At the fourth month the IgG level began to rise continuously (P < 0.01). The infants who were vaccinated at the second month showed a higher IgM response at the second and fourth month than those vaccinated in the first month (P < 0.05), but the difference was not visible thereafter (P > 0.05). 52 infants (78%) were tuberculin positive 8 weeks after vaccination.
CONCLUSION: Anti-PPD IgM and IgG levels rise progressively in BCG-vaccinated infants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548909     DOI: 10.1016/s0962-8479(05)80013-9

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  16 in total

1.  Bacillus Calmette-Guérin vaccination using a microneedle patch.

Authors:  Yasuhiro Hiraishi; Subhadra Nandakumar; Seong-O Choi; Jeong Woo Lee; Yeu-Chun Kim; James E Posey; Suraj B Sable; Mark R Prausnitz
Journal:  Vaccine       Date:  2011-01-28       Impact factor: 3.641

Review 2.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 3.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

4.  Serum anti-Mce1A immunoglobulin detection as a tool for differential diagnosis of tuberculosis and latent tuberculosis infection in children and adolescents.

Authors:  Christiane M Schmidt; Kathryn L Lovero; Fabiana R Carvalho; Daniele C M Dos Santos; Ana Cláudia M W Barros; Ana Paula Quintanilha; Ana Paula Barbosa; Marcos V S Pone; Sheila M Pone; Julienne Martins Araujo; Camila de Paula Martins; Solange G D Macedo; Ana Lúcia Miceli; Maria Luíza Vieira; Selma M A Sias; Adriano Queiroz; Luis Guillermo Coca Velarde; Afranio L Kritski; Andrea A Silva; Clemax C Sant'Anna; Lee W Riley; Claudete A Araújo Cardoso
Journal:  Tuberculosis (Edinb)       Date:  2019-12-05       Impact factor: 3.131

Review 5.  Antibody responses to mycobacterial antigens in children with tuberculosis: challenges and potential diagnostic value.

Authors:  Jacqueline M Achkar; Anke Ziegenbalg
Journal:  Clin Vaccine Immunol       Date:  2012-10-24

Review 6.  Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

7.  Mycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients.

Authors:  Mani H Vemula; Rakesh Ganji; Ramya Sivangala; Kiran Jakkala; Sumanlatha Gaddam; Sitaramaraju Penmetsa; Sharmistha Banerjee
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

8.  T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Authors:  Helen A Fletcher; Margaret A Snowden; Bernard Landry; Wasima Rida; Iman Satti; Stephanie A Harris; Magali Matsumiya; Rachel Tanner; Matthew K O'Shea; Veerabadran Dheenadhayalan; Leah Bogardus; Lisa Stockdale; Leanne Marsay; Agnieszka Chomka; Rachel Harrington-Kandt; Zita-Rose Manjaly-Thomas; Vivek Naranbhai; Elena Stylianou; Fatoumatta Darboe; Adam Penn-Nicholson; Elisa Nemes; Mark Hatherill; Gregory Hussey; Hassan Mahomed; Michele Tameris; J Bruce McClain; Thomas G Evans; Willem A Hanekom; Thomas J Scriba; Helen McShane
Journal:  Nat Commun       Date:  2016-04-12       Impact factor: 14.919

Review 9.  TB vaccine development and the End TB Strategy: importance and current status.

Authors:  Helen A Fletcher; Lewis Schrager
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-04       Impact factor: 2.184

10.  Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.

Authors:  Mamiko Niki; Maho Suzukawa; Shunsuke Akashi; Hideaki Nagai; Ken Ohta; Manabu Inoue; Makoto Niki; Yukihiro Kaneko; Kozo Morimoto; Atsuyuki Kurashima; Seigo Kitada; Sohkichi Matsumoto; Koichi Suzuki; Yoshihiko Hoshino
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.